231 related articles for article (PubMed ID: 23663316)
1. In vitro study of isoflavones and isoflavans as potent inhibitors of human 12- and 15-lipoxygenases.
Mascayano C; Espinosa V; Sepúlveda-Boza S; Hoobler EK; Perry S
Chem Biol Drug Des; 2013 Sep; 82(3):317-25. PubMed ID: 23663316
[TBL] [Abstract][Full Text] [Related]
2. Easy and rapid preparation of benzoylhydrazides and their diazene derivatives as inhibitors of 15-lipoxygenase.
Tirapegui C; Acevedo-Fuentes W; Dahech P; Torrent C; Barrias P; Rojas-Poblete M; Mascayano C
Bioorg Med Chem Lett; 2017 Apr; 27(8):1649-1653. PubMed ID: 28318946
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
ElBordiny HS; El-Miligy MM; Kassab SE; Daabees H; Mohamed Ali WA; Abdelhamid Mohamed El-Hawash S
Eur J Med Chem; 2018 Feb; 145():594-605. PubMed ID: 29339254
[TBL] [Abstract][Full Text] [Related]
4. Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1.
Eleftheriadis N; Thee S; te Biesebeek J; van der Wouden P; Baas BJ; Dekker FJ
Eur J Med Chem; 2015 Apr; 94():265-75. PubMed ID: 25771032
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors.
Iranshahi M; Jabbari A; Orafaie A; Mehri R; Zeraatkar S; Ahmadi T; Alimardani M; Sadeghian H
Eur J Med Chem; 2012 Nov; 57():134-42. PubMed ID: 23047230
[TBL] [Abstract][Full Text] [Related]
6. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase.
Chen YP; Zhang ZY; Li YP; Li D; Huang SL; Gu LQ; Xu J; Huang ZS
Eur J Med Chem; 2013 Aug; 66():22-31. PubMed ID: 23786711
[TBL] [Abstract][Full Text] [Related]
7. Novel human lipoxygenase inhibitors discovered using virtual screening with homology models.
Kenyon V; Chorny I; Carvajal WJ; Holman TR; Jacobson MP
J Med Chem; 2006 Feb; 49(4):1356-63. PubMed ID: 16480270
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-Lipoxygenase inhibitors.
Ali SA; Awad SM; Said AM; Mahgoub S; Taha H; Ahmed NM
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):847-863. PubMed ID: 32216479
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
10. The N-terminal β-barrel domain of mammalian lipoxygenases including mouse 5-lipoxygenase is not essential for catalytic activity and membrane binding but exhibits regulatory functions.
Walther M; Hofheinz K; Vogel R; Roffeis J; Kühn H
Arch Biochem Biophys; 2011 Dec; 516(1):1-9. PubMed ID: 21951814
[TBL] [Abstract][Full Text] [Related]
11. Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases.
Deschamps JD; Kenyon VA; Holman TR
Bioorg Med Chem; 2006 Jun; 14(12):4295-301. PubMed ID: 16500106
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic Studies of Isoflavonoids as Selective and Potent Inhibitors of Human Leukocyte 5-Lipo-Oxygenase.
Mascayano C; Espinosa V; Sepúlveda-Boza S; Hoobler EK; Perry S; Diaz G; Holman TR
Chem Biol Drug Des; 2015 Jul; 86(1):114-21. PubMed ID: 25359714
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.
Vasquez-Martinez Y; Ohri RV; Kenyon V; Holman TR; Sepúlveda-Boza S
Bioorg Med Chem; 2007 Dec; 15(23):7408-25. PubMed ID: 17869117
[TBL] [Abstract][Full Text] [Related]
14. Effect of catechol derivatives on cell growth and lipoxygenase activity.
Simpson J; Forrester R; Tisdale MJ; Billington DC; Rathbone DL
Bioorg Med Chem Lett; 2003 Aug; 13(15):2435-9. PubMed ID: 12852938
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of purine-pyrazole hybrids incorporating thiazole, thiazolidinone or rhodanine moiety as 15-LOX inhibitors endowed with anticancer and antioxidant potential.
Afifi OS; Shaaban OG; Abd El Razik HA; Shams El-Dine SEA; Ashour FA; El-Tombary AA; Abu-Serie MM
Bioorg Chem; 2019 Jun; 87():821-837. PubMed ID: 30999135
[TBL] [Abstract][Full Text] [Related]
16. New isoflavonoids as inhibitors of porcine 5-lipoxygenase.
Voss C; Sepulveda-Boza S; Zilliken FW
Biochem Pharmacol; 1992 Jul; 44(1):157-62. PubMed ID: 1632829
[TBL] [Abstract][Full Text] [Related]
17. Molecular-dynamics simulation of dioxygen egress from 12/15-lipoxygenase-arachidonic acid complex.
Pietra F
Chem Biodivers; 2012 Jun; 9(6):1019-32. PubMed ID: 22700222
[TBL] [Abstract][Full Text] [Related]
18. Phenylalanine 353 is a primary determinant for the positional specificity of mammalian 15-lipoxygenases.
Borngräber S; Kuban RJ; Anton M; Kühn H
J Mol Biol; 1996 Dec; 264(5):1145-53. PubMed ID: 9000636
[TBL] [Abstract][Full Text] [Related]
19. Identification of 1, 4-Dihydrothieno [3', 2':5, 6]thiopyrano[4, 3-c] pyrazole derivatives as human 5-Lipo-oxygenase inhibitors.
Hu J; Zhu W; Meng H; Liu Y; Wang X; Hu C
Chem Biol Drug Des; 2014 Dec; 84(6):642-7. PubMed ID: 24889744
[TBL] [Abstract][Full Text] [Related]
20. Exploration of binding site pattern in arachidonic acid metabolizing enzymes, Cyclooxygenases and Lipoxygenases.
Reddy KK; Vidya Rajan VK; Gupta A; Aparoy P; Reddanna P
BMC Res Notes; 2015 Apr; 8():152. PubMed ID: 25886468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
